Apstatin is a potent and selective inhibitor of aminopeptidase P (APP), Ki=2.6 µM for purified rat lung membrane-bound APP. It blocks the APP-mediated degradation of bradykinin. Limits myocardial infarct size alone or with ACE inhibitors.
Product Details
Alternative Name: | N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-prolyl-L-prolyl-L-alaninamide |
|
Sequence: | N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-prolyl-L-prolyl-L-alaninamide |
|
Formula: | C23H33N5O5 |
|
MW: | 459.5 |
|
CAS: | 160470-73-5 |
|
Formulation: | Lyophilized. |
|
Purity: | ≥95% (HPLC) |
|
Appearance: | Solid. |
|
Solubility: | Soluble in water (>25 mg/ml) or DMSO (20 mg/ml). |
|
Shipping: | Shipped on Blue Ice |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over